Novo Nordisk A/S (NVO)
123.05
-0.97
(-0.78%)
USD |
NYSE |
May 03, 16:00
123.01
-0.04
(-0.03%)
After-Hours: 20:00
Novo Nordisk Free Cash Flow: 7.330B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 7.330B |
December 31, 2023 | 10.16B |
September 30, 2023 | 11.76B |
June 30, 2023 | 9.713B |
March 31, 2023 | 9.409B |
December 31, 2022 | 9.092B |
September 30, 2022 | 7.739B |
June 30, 2022 | 8.391B |
March 31, 2022 | 9.284B |
December 31, 2021 | 7.577B |
September 30, 2021 | 6.278B |
June 30, 2021 | 5.340B |
March 31, 2021 | 4.935B |
December 31, 2020 | 4.577B |
September 30, 2020 | 7.055B |
June 30, 2020 | 7.060B |
March 31, 2020 | 5.511B |
December 31, 2019 | 5.331B |
September 30, 2019 | 5.583B |
June 30, 2019 | 4.762B |
March 31, 2019 | 5.013B |
December 31, 2018 | 5.102B |
September 30, 2018 | 4.741B |
June 30, 2018 | 5.386B |
March 31, 2018 | 4.593B |
Date | Value |
---|---|
December 31, 2017 | 4.950B |
September 30, 2017 | 5.902B |
June 30, 2017 | 5.837B |
March 31, 2017 | 6.504B |
December 31, 2016 | 5.952B |
September 30, 2016 | 5.776B |
June 30, 2016 | 5.544B |
March 31, 2016 | 5.178B |
December 31, 2015 | 4.743B |
September 30, 2015 | 4.753B |
June 30, 2015 | 5.048B |
March 31, 2015 | 4.785B |
December 31, 2014 | 4.884B |
September 30, 2014 | 4.655B |
June 30, 2014 | 3.700B |
March 31, 2014 | 3.478B |
December 31, 2013 | 3.971B |
September 30, 2013 | 3.312B |
June 30, 2013 | 3.461B |
March 31, 2013 | 3.417B |
December 31, 2012 | 3.211B |
September 30, 2012 | 3.517B |
June 30, 2012 | 3.720B |
March 31, 2012 | 3.431B |
December 31, 2011 | 3.370B |
Free Cash Flow Range, Past 5 Years
4.577B
Minimum
Dec 2020
11.76B
Maximum
Sep 2023
7.345B
Average
7.195B
Median
Free Cash Flow Benchmarks
Amgen Inc | 7.098B |
Vertex Pharmaceuticals Inc | 3.279B |
Viking Therapeutics Inc | -54.87M |
Evaxion Biotech AS | -- |
Moderna Inc | -3.672B |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 2.085B |
Cash from Investing (Quarterly) | 576.22M |
Cash from Financing (Quarterly) | -3.843B |
Free Cash Flow Per Share (Quarterly) | 0.1728 |
Free Cash Flow to Equity (Quarterly) | 36.93M |
Free Cash Flow to Firm (Quarterly) | 772.71M |
Free Cash Flow Yield | 1.33% |